Science Corporation wins EU approval for PRIMA retinal implant, first BCI to restore reading vision

Science Corporation received CE mark approval to sell PRIMA, a retinal implant that restores form vision — including reading letters and words — to patients blinded by late-stage age-related macular degeneration. It is the first brain-computer interface device to receive CE marking for form vision restoration. PRIMA pairs an implantable chip with camera-equipped glasses. First commercial procedure in Europe could occur as early as September 2026.